Brian MacDonald
No más puestos en curso
Fortuna: 412 757 $ al 30/04/2024
Perfil
Brian MacDonald is the founder of Disc Medicine Opco, Inc. He previously worked as the Chief Innovation Officer at Disc Medicine, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DISC MEDICINE, INC.
0.06% | 30/06/2023 | 15 564 ( 0.06% ) | 412 757 $ | 30/04/2024 |
Antiguos cargos conocidos de Brian MacDonald.
| Empresas | Cargo | Fin |
|---|---|---|
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Director Ejecutivo | 25/02/2020 |
| DISC MEDICINE, INC. | Director Técnico/Científico/I+D | 20/12/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DISC MEDICINE, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Brian MacDonald
